Literature DB >> 15358240

Insights into function of PSI domains from structure of the Met receptor PSI domain.

Guennadi Kozlov1, Audrey Perreault, Joseph D Schrag, Morag Park, Miroslaw Cygler, Kalle Gehring, Irena Ekiel.   

Abstract

PSI domains are cysteine-rich modules found in extracellular fragments of hundreds of signaling proteins, including plexins, semaphorins, integrins, and attractins. Here, we report the solution structure of the PSI domain from the human Met receptor, a receptor tyrosine kinase critical for proliferation, motility, and differentiation. The structure represents a cysteine knot with short regions of secondary structure including a three-stranded antiparallel beta-sheet and two alpha-helices. All eight cysteines are involved in disulfide bonds with the pattern consistent with that for the PSI domain from Sema4D. Comparison with the Sema4D structure identifies a structurally conserved core comprising the N-terminal half of the PSI domain. Interestingly, this part links adjacent SEMA and immunoglobulin domains in the Sema4D structure, suggesting that the PSI domain serves as a wedge between propeller and immunoglobulin domains and is responsible for the correct positioning of the ligand-binding site of the receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358240     DOI: 10.1016/j.bbrc.2004.06.132

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Targeting the HGF/Met signaling pathway in cancer therapy.

Authors:  Fabiola Cecchi; Danie C Rabe; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

Review 2.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

Review 3.  Semaphorin 5A mediated cellular navigation: connecting nervous system and cancer.

Authors:  Abhilasha Purohit; Anguraj Sadanandam; Pavan Myneni; Rakesh K Singh
Journal:  Biochim Biophys Acta       Date:  2014-09-28

4.  Evidence that monoclonal antibodies directed against the integrin beta subunit plexin/semaphorin/integrin domain stimulate function by inducing receptor extension.

Authors:  A Paul Mould; Mark A Travis; Stephanie J Barton; Jennifer A Hamilton; Janet A Askari; Susan E Craig; Philip R Macdonald; Richard A Kammerer; Patrick A Buckley; Martin J Humphries
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

5.  The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer.

Authors:  Fabiola Cecchi; Daniel C Rabe; Donald P Bottaro
Journal:  Curr Signal Transduct Ther       Date:  2011

6.  Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein.

Authors:  Kinlin L Chao; Natalia V Gorlatova; Edward Eisenstein; Osnat Herzberg
Journal:  J Biol Chem       Date:  2014-09-05       Impact factor: 5.157

Review 7.  MET targeting: time for a rematch.

Authors:  Jonas P Koch; Daniel M Aebersold; Yitzhak Zimmer; Michaela Medová
Journal:  Oncogene       Date:  2020-02-07       Impact factor: 8.756

8.  Palmitoylation regulates the intracellular trafficking and stability of c-Met.

Authors:  David T Coleman; Alana L Gray; Steven J Kridel; James A Cardelli
Journal:  Oncotarget       Date:  2016-05-31

9.  Crystal structure of the Sema-PSI extracellular domain of human RON receptor tyrosine kinase.

Authors:  Kinlin L Chao; I-Wei Tsai; Chen Chen; Osnat Herzberg
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met.

Authors:  Cristina Basilico; Addolorata Arnesano; Maria Galluzzo; Paolo M Comoglio; Paolo Michieli
Journal:  J Biol Chem       Date:  2008-05-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.